FIELD: organic chemistry, pharmacy. SUBSTANCE: invention proposes derivatives of [1,2,4]-triazolo-[4,3-a] of the general formula (I) where R1 means linear or branched C1-6-alkyl, substituted COX' or POX'X'' where X' and X'' means independently hydroxyl- or alkoxy-group; R6 and R9 mean hydrogen atom; R7 means CF3 and R8 means imidazolyl, piperidino- or morpholino-group being their rings are optionally substituted with one or two substituents taken among phenyl and C1-6-alkyl, or their pharmaceutically acceptable salts. Compounds of the formula (I) show antagonistic activity with respect to AMPA-receptors and are useful for treatment of patients with symptoms of hyperactivity of exciting neuromediators. Invention proposes also method of synthesis of compounds of the formula (I), pharmaceutical composition based on said and method of inhibition of AMPA-receptors activity. EFFECT: improved method of synthesis, valuable pharmacological properties. 8 cl, 1 tbl, 13 ex
Title |
Year |
Author |
Number |
DERIVATIVES OF CONDENSED 1,2,4-THIADIAZINE AND CONDENSED 1,4-THIAZINE, THEIR SYNTHESIS AND USING |
1997 |
- Nil'Sen Flemming Ehl'Melunn
- Khansen Khol'Ger Klaus
- Khansen Jokhn Bondo
- Tagmose Tina Meller
|
RU2199542C2 |
2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND METHODS OF SYNTHESIS |
1993 |
- Kristian Foged
- Rol'F Kholveg
- Ehrik Bardrum Nil'Sen
|
RU2114839C1 |
SUBSTITUTED MORPHOLINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF COUNTERACTION TO SUBSTANCE P OR INHIBITION OF NEUROKININ-1 RECEPTORS |
1995 |
- Konrad P. Dorn
- Dzheffri Dzh. Khejl
- Mal'Kol'M Makkoss
- Sander G. Mills
|
RU2170233C2 |
CONDENSED DERIVATIVE OF 1,2,4-THIADIAZINE, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING MEDICINE |
1998 |
- Nil'Sen Flemming Ehl'Medlunn
- Khansen Jokhn Bondo
- Khansen Khol'Ger Klaus
- Tagmose Tina Meller
- Mogensen Jokhn Patrik
|
RU2215004C2 |
DERIVATIVES OF PYRIDO-1,2,4-THIADIAZINE OR PYRIDO-1,4-THIAZINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF MANIFESTATION OF ACTIVITY INHIBITING INSULIN SECRETION |
1997 |
- Pirott Bernar
- Lebren Filip
- De Tjull'O Paskal'
- Somer Fabian
- Delarzh Zhak Ehli
- Khansen Khol'Ger Klaus
- Nil'Sen Flemming Ehl'Melunn
- Khansen Jokhn Bondo
|
RU2193564C2 |
PHTHALAZINE KETONE DERIVATIVE, METHOD OF OBTAINING THEREOF AND PHARMACEUTICAL APPLICATION |
2011 |
- Tan Pehn Cho
- Li Sin'
- Li Sjantsin'
- Chehn' Jan
- Van Bin'
- Chzhu Chzhe
|
RU2564527C2 |
N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF INHIBITION OF NEUROGENIC INFLAMMATION |
1995 |
- Knud Ehrik Andersen
- Uffe Bang Ol'Sen
- Khans Petersen
- Frederik Kristian Grenval'D
- Ursula Sonneval'D
- Tine Krog Jergensen
- Khenrik Sune Andersen
|
RU2167152C2 |
SUBSTITUTED HETEROCYCLES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION FOR BLOCKADE OF NEUROKININ-1 RECEPTORS IN MAMMALS, METHOD OF BLOCKADE OF NEUROKININ-1 RECEPTORS IN MAMMALS |
1993 |
- Konrad P.Dorn
- Dzheffri Dzh.Khejl
- Mal'Kol'M Mehkkoss
- Sander Dzh.Millz
- Tamara Lehdduvakhetti
- Shrenik K.Shakh
|
RU2140914C1 |
DIPHENYL HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT |
1997 |
- Romin Dzheffri L.
- Martin Skott V.
- Khevavasam Piasena
- Minvell Nikolas A.
- Gribkoff Valentin K.
- Stehrrett Dzhon E. Dzhr.
|
RU2175319C2 |
COMPOUNDS AND THEIR USING FOR DECREASING HORMONE-SENSITIVE LIPASE ACTIVITY |
2002 |
- Ehbdrup Seren
- Kornelis De Jong Jokhannes
- Jakobsen Paul'
- Khansen Khol'Ger Klaus
- Vedse Per
|
RU2317981C2 |